The mesothelium is a flat epithelial-like cell lining covering the surface of the pleural. penrcardial and peritoneal cavities and the serous surface of various organs located in these cavities. It has long been a practical problem for surgical pathologists to distinguish the mesothelium from the epithelium and make a positive diagnosis of mesothelioma, a tumour of mesothelial cell origin, because of its histological similarity to epithelial tumours and the variation in its histology. Mesothelioma is not a common malignancy in humans, but epidemiological studies have established a relationship between malignant mesothelioma and exposure to asbestos fibres (Craighead and Mossman, 1982) . Definitive diagnosis of mesothelioma is necessary not only for making decisions regarding therapy and prognosis, but also for prevention of this life-threatening disease.
Although long and slender cytoplasmic processes are known to be one of the characteristic ultrastructural features of mesothelium and mesothelioma (Warhol et al., 1982) , electron microscopy is a rather troublesome procedure, and impractical for routine pathological diagnosis. In order to discriminate between mesothelium and epithelium, numerous immunohistochemical and immunocytochemical studies have been performed using panels of antibodies against epithelial cell markers with various degrees of specificity and sensitivity, including carcinoembryonic antigen (CEA), epithelial antigen (EA), Leu-MI, Tn antigen and the B72.3 antigen, as reviewed previously (Sheibani et al., 1992) . However, these epithelial cell-surface markers cannot be used for positive identification of mesothelium and mesothelioma.
In contrast, relatively few immunohistochemical studies have been done using newly established polyclonal (Donna et al., 1988) or monoclonal (Hsu S-H et al., 1988; Stahel et al., 1988; O'Hara et al., 1990; Chang et al., 1992) antibodies directed against mesothelium. Those include ME-1 (Stahel et al., 1988; O'Hara et al., 1990) and K-1 (Chang et al., 1992) . Again, however, there is some limitation in the use of these monoclonal antibodies. For example, ME-1 reacts with poorly differentiated adenocarcinoma and K-1 reacts with ovarian carcinoma and squamous cell carcinoma.
In this study, we developed a new monoclonal antibody, designated MS-2761, against cultured non-neoplastic mesothelial cells. We found that the antigen was expressed in all non-neoplastic mesothelium and mesothelioma cells examined, but was not expressed in epithelium and most epithelial tumour cells in vivo and in vitro. Because of its possible value for differential diagnosis of mesothelioma and mesothelial cells and its unique tissue distribution, we decided to carry out molecular cloning of the gene encoding the cell-surface antigen defined by this monoclonal antibody using a mammalian cell expression vector and immunoselection (Seed and Aruffo, 1987) .
Materials and methods

Cell culture and cell tines
Mesothelial cells from six patients were separated from peritoneal omentum, which had been removed during resection of stomach cancer, by brief trypsinisation as described previously (Kern et al., 1983; Takahashi et al., 1989 The immunoperoxidase staining procedures were performed as described previously (Sato et al., 1986 The cDNA inserts of clones were sequenced by the dideoxy chain-termination method (Sanger et al., 1977 ) using a Sequenase 7-deaza-dGTP kit from United States Biochemicals (Cleveland, OH, USA).
Northern blot analysis
Northern blot analysis was performed essentially as described previously (Sambrook et al., 1989 Immwwhistochemical reactivity of MS-2761 (Figures 2 and 3 and (Figure 2a) . Among the seven cases of malignant mesothelioma, two were classifie as monophasic epithelioid or fibrous mesothelioma and five as biphasic mesothelioma. In epithelioid mesothelioma or the epithelioid component of biphasic mesothelioma, the MS-2761 antigen was expressed on the inner surface of the gland-like spaces formed by the tumour cells (Figure 2b ) or in the cytoplasm of the tumour cells (Figure 2c ). When compared with T Yamada et a epithelioid mesothelioma, the staining itensity of fibrous mesothelioma or the sarcomatous component of biphasic mesothelioma was relatively faint and the cytoplasm of the tumour cells was stained ( Figure 2d ).
As shown in (Figure 2e ). This staining pattern was not observed in epithelioid mesothelioma. In one case of lung adenocarcinoma, a small number (< 5%) of tumour cells at the edge (or the proliferation tip) showed membranous staining (Figure 2f ).
4k. Although tumour cells were not stained with MS-2761, strong staining was observed in the fibrous stroma of most epithelial tumours (Figure 3a) .
In non-neoplastic issues obtained at autopsy, mesothelium (Figure 3b jected to SDS-PAGE and autoradiography. Under reducing conditions, a major and rather broad band at 106-112 kDa and a minor and sharp band at 97 kDa were detected ( Figure  4 , lane A). After N-glycosidase treatment, which cleaves between the innermost N-acetylglicosamine (GlcNAc) and asparagine residue of glycoprotein (Tarentino et al., 1990 ), a single band at 80-82 kDa was detected (Figure 4, DNA sequencing and database search As shown in Figure 5 , DNA sequencing and restriction mapping revealed that the two cDNA clones shared an identical 5' end sequence and an identical open reading frame but different polyadenylation sites. A database search revealed that the nucleotide sequence was identical to the cDNA of vascular cell adhesion molecule 1 (VCAM 1), which was originally cloned from an expression library of cytokineactivated endothelial cells (Osborn et al., 1989) . Both pMS2761-32 and pMS2761-28 had four additional nucleotides (GCAT) at the 5' end of the registered VCAM1 cDNA sequence, but lacked seven nucleotides from the transcriptional start site determined by primer extension analysis (Cybulsky et al., 1991b) .
Northern blotting (Figure 6 RT-PCR (Figure 7 ) In endothelial cells, alternative splicng results in two different mRNAs encoding VCAM1 with six or seven Ig-ke domain (Cybulsky et al., 1991a; Hession et al., 1991 (TNF-z) (Osborn et al., 1989) . Through its interaction with integrin aJ1 (Elices et al., 1990) , VCAM1 acts as an adhesion molecule of endothelial cells to lymphocytes, monocytes, eosinophils and basophils, and is thought to initiate the extravasation of these inflammatory cells (Briscoe et al., 1992) . The expression of VCAM1 in inflammatory sites suggests its involvement in the pathogenesis of inflammatory diseases (Rice et al., 1991) .
Non-vascular cells expressing VCAM1 are reported to include follicular dendritic cells of lymph nodes, bone marrow stroma cells and synovial cells (Freedman et al., 1990; Rice et al., 1991; Simmons et al., 1992) . Taking into consideration the morphological and functional similarity between endothelium and mesothelium, it is not surprising that endothelium and mesothelium share such a cell-surface molecule. The in vivo expression of VCAM1 in mesothelium was described by Rice et al. (1991) , but it has not been examined in further detail, except for a few sporadic in vitro studies (Jonjic et al., 1992; Cannistra et al., 1993 In Northern blotting, a prominent 3.2 kb transcript of VCAM1 was detected in non-neoplastic mesothelial cells. In addition, two minor transcripts, 5.0 and 7.5 kb in size, were also detected. These longer transcripts have not been described in the literature and are now under investigation.
RT-PCR revealed that non-neoplastic mesothelial cells expressed VCAM1 with both of six and seven Ig-like domains, imilar to cytokine-activated endothelial cells (Cybulsky et al., 1991a; Hession et al., 1991) . In this study, two near-full legth cDNAs of VCAM1 were separated by expression cDNA cloning. Tmese two cDNA clones shared identical 5' end sequencs but had different polyadenylation sites. It is likely that the shorter cDNA done was the result of DNA recombination during the cloning procedures including repeated transformation into E. coli and DNA transfection into Cos-7 monkey cells. However, the shorter cDNA clone had a sequence identical to the longer one and a polyadenylation site proceded by the consensus poly(A) signal sequence, AATAAA. This implies the presence of a minor differently polyadenylated population of VCAM1 mRNA which has not been detected before. CEA and NCAM (Patel et al., 1989) are among those used most commonly. This is probably due to the relatively restricted tissue distribution of this family. Although a larger series of tumours with different histological patterns needs to be studied to confirm the specificity, this monoclonal antibody seems to have a potential value for discrimination of mesothelium and epithelium, and further studies of VCAMI should provide insight into the functional properties of mesothelium.
